Christina Carr

Christina Carr has an extensive work experience spanning over two decades. Their most recent position is Senior Director, Clinical Quality Assurance at Marinus Pharma, where they have been working since June 2022. Prior to that, they served as Director, Preclinical & Clinical Quality Assurance at ImmunityBio, Inc. from August 2021 to June 2022.

Before joining ImmunityBio, Inc., Christina Carr was the Director of Quality Assurance at Clinlogix from March 2019 to August 2021. Christina also worked as an Auditor II, Quality Assurance at PAREXEL from June 2018 to March 2019 and as a Senior QA Auditor II at Concord Biosciences, LLC from November 2016 to March 2018.

From February 2016 to November 2016, Christina Carr worked as an Independent Consultant. Prior to that, they served as the Director of Global RA & QA at Cellular Technology Limited (CTL) for over a decade, from February 2005 to 2016.

Christina Carr has also held positions such as Director, Quality Assurance at ChanTest Corporation from February 2001 to February 2005, Regulatory/Enrollment Coordinator at West Pharmaceutical Services, Inc. from February 2000 to February 2001, and Quality Assurance Auditor at Boehringer Ingelheim from July 1999 to February 2000.

Christina Carr completed their Bachelor of Arts (BA) degree in Biology at West Virginia University from 1992 to 1996. Prior to that, they attended Braxton County High School from 1988 to 1992 and obtained their High School degree. In 2002, Christina Carr also earned the RQAP-GLP certification from the Society of Quality Assurance.